Louisiana 2021 2021 Regular Session

Louisiana Senate Bill SB168 Comm Sub / Analysis

                    The original instrument and the following digest, which constitutes no part of the
legislative instrument, were prepared by Brandi Cannon.
DIGEST
SB 168 Original	2021 Regular Session	Fred Mills
Present law provides for the designation of controlled dangerous substances into Schedules I, II, III,
IV, and V based upon the substances' potential for addiction and abuse.
Proposed law adds Beta-hydroxythiofentanyl, Brorphine, Crotonyl fentanyl, Cyclopentyl fentanyl,
Isobutyryl fentanyl, Para-chloroisobutyryl fentanyl, Para-methoxybutyryl fentanyl, and Valeryl
fentanyl to Schedule I.
Proposed law adds Oliceridine to Schedule II.
Proposed law adds Remimazolam to Schedule IV.
Proposed law removes cannabidiol when contained in a drug product approved by the U.S. Food and
Drug Administration from Schedule V.
Effective August 1, 2021.
(Adds R.S. 40:964(Schedule I)(A)(72)-(79), (Schedule II)(B)(30), and (Schedule IV)(B)(57); repeals
R.S. 40:964(Schedule V)(F))